UAB 1753 A Randomized Placebo Controlled Phase II Trial of Metformin in Conjunction with Chemotherapy Followed by Metformin Maintenance Therapy in Advanced Stage Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Grant

Date/time Interval

  • February 28, 2018 - February 27, 2023
  • Awarded By

    Total Award Amount

  • 67500.00
  • Direct Costs

  • 51925.00
  • Sponsor Award Id

  • Contributor

  • Charles Leath M.D.   Investigator  
  • John Straughn M.D.   Investigator  
  • Kerri Bevis M.D.   Investigator  
  • Rebecca Arend M.D.   Investigator  
  • Warner Huh M.D.   Principal Investigator